Cargando…
Drug Repositioning for COVID-19
Drug repositioning is a strategy that identifies new uses of approved drugs to treat conditions different from their original purpose. With the advance of COVID-19 and the pandemic declaration; It has become the closest alternative to reduce the advance of the virus. Antimalarial, antiviral drugs, a...
Autor principal: | Benavides-Cordoba, Vicente |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Universidad del Valle
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518729/ https://www.ncbi.nlm.nih.gov/pubmed/33012890 http://dx.doi.org/10.25100/cm.v51i2.4279 |
Ejemplares similares
-
Current Status of COVID-19 Therapies and Drug Repositioning Applications
por: Altay, Ozlem, et al.
Publicado: (2020) -
The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic
por: Won, Jung-Hyun, et al.
Publicado: (2020) -
COVID-19: Analysis of Drug Repositioning Practice
por: Savosina, P. I., et al.
Publicado: (2021) -
Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022) -
Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012)